Relief Therapeutics Holding Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Michelle Lock
Chief executive officer
CHF92.5k
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 1.3yrs |
Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Health Check: How Prudently Does Relief Therapeutics Holding (VTX:RLF) Use Debt?
May 05Does Relief Therapeutics Holding (VTX:RLF) Have A Healthy Balance Sheet?
Oct 04Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?
Apr 23Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?
Sep 25We Wouldn't Rely On Relief Therapeutics Holding's (VTX:RLF) Statutory Earnings As A Guide
Jan 13CEO
Michelle Lock (55 yo)
less than a year
Tenure
CHF92,473
Compensation
Ms. Michelle Lock serves as the Interim Chief Executive Officer and Director since November 22, 2023 at Relief Therapeutics Holding AG and served as its Independent Director from January 28, 2022. She serv...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Interim CEO & Director | less than a year | CHF92.47k | no data | |
CFO & Treasurer | 1.3yrs | no data | 0.0028% CHF 440.5 | |
Chief Operating Officer | 1.5yrs | CHF150.00k | 0.62% CHF 97.6k |
1.3yrs
Average Tenure
55yo
Average Age
Experienced Management: RLF's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Interim CEO & Director | 2.3yrs | CHF92.47k | no data | |
Chairman of the Board | 7.9yrs | CHF500.00k | no data | |
Vice-Chairman | 3.3yrs | CHF150.00k | 0.010% CHF 1.6k | |
Independent Director | 2.8yrs | CHF150.00k | 0.0028% CHF 437.3 |
3.1yrs
Average Tenure
53.5yo
Average Age
Experienced Board: RLF's board of directors are considered experienced (3.1 years average tenure).